Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women

References

• Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362: 419–427
   PubMed Web of Science ®Google Scholar
• Chlebowski R T, Hendrix S L, Langer R D, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial. JAMA 2003; 289: 3243–3253
   PubMed Web of Science ®Google Scholar
• Boyd N F, Lockwood G A, Byng J W, Tritchler D L, Yaffe M J. Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998; 7: 1133–1144
   PubMed Web of Science ®Google Scholar
• Byrne C, Schairer C, Wolfe J, et al. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 1995; 87: 1622–1629
   PubMed Web of Science ®Google Scholar
• Ursin G, Ma H, Wu A H, et al. Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev 2003; 12: 332–338
   PubMed Web of Science ®Google Scholar
• McCormack V A, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15: 1159–1169
   PubMed Web of Science ®Google Scholar
• Boyd N F, Guo H, Martin L J, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007; 356: 227–236
   PubMed Web of Science ®Google Scholar
• Spicer D V, Ursin G, Parisky Y, et al. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst 1994; 86: 431–436
   PubMed Web of Science ®Google Scholar
• Atkinson C, Warren R, Bingham S A, Day N E. Mammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen. Cancer Epidemiol Biomarkers Prev 1999; 8: 863–866
   PubMed Web of Science ®Google Scholar
• Yaffe M, Boyd N. Mammographic breast density and cancer risk: the radiological view. Gynecol Endocrinol 2005; 21(Suppl 1)6–11
   PubMedGoogle Scholar
• Harvey J A, Santen R J, Petroni G R, et al. Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices. Menopause 2008; 15: 67–73
   PubMed Web of Science ®Google Scholar
• Rossouw J E, Anderson G L, Prentice R L, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–333
   PubMed Web of Science ®Google Scholar
• Lee S A, Ross R K, Pike M C. An overview of menopausal oestrogen-progestin hormone therapy and breast cancer risk. Br J Cancer 2005; 92: 2049–2058
   PubMed Web of Science ®Google Scholar
• Bremnes Y, Ursin G, Bjurstam N, Lund E, Gram I T. Different types of postmenopausal hormone therapy and mammographic density in Norwegian women. Int J Cancer 2007; 120: 880–884
   PubMed Web of Science ®Google Scholar
• Christodoulakos G E, Lambrinoudaki I V, Vourtsi A D, et al. The effect of low dose hormone therapy on mammographic breast density. Maturitas 2006; 54: 78–85
   PubMed Web of Science ®Google Scholar
• Lundstrom E, Bygdeson M, Svane G, Azavedo E, von Schoultz B. Neutral effect of ultra-low-dose continuous combined estradiol and norethisterone acetate on mammographic breast density. Climacteric 2007; 10: 249–256
   PubMed Web of Science ®Google Scholar
• Ursin G, Astrahan M A, Salane M, et al. The detection of changes in mammographic densities. Cancer Epidemiol Biomarkers Prev 1998; 7: 43–47
   PubMed Web of Science ®Google Scholar
• Greendale G A, Reboussin B A, Slone S, et al. Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 2003; 95: 30–37
   PubMed Web of Science ®Google Scholar
• McTiernan A, Martin C F, Peck J D, et al. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial. J Natl Cancer Inst 2005; 97: 1366–1376
   PubMed Web of Science ®Google Scholar
• Lundstrom E, Wilczek B, von Palffy Z, Soderqvist G, von Schoultz B. Mammographic breast density during hormone replacement therapy: differences according to treatment. Am J Obstet Gynecol 1999; 181: 348–352
   PubMed Web of Science ®Google Scholar
• Greendale G A, Reboussin B A, Sie A, et al. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. Ann Intern Med 1999; 130: 262–369
   PubMed Web of Science ®Google Scholar
• Sala E, Warren R, McCann J, et al. High-risk mammographic parenchymal patterns, hormone replacement therapy and other risk factors: a case-control study. Int J Epidemiol 2000; 29: 629–636
   PubMed Web of Science ®Google Scholar
• Christodoulakos G E, Lambrinoudaki I V, Panoulis K P, et al. The effect of various regimens of hormone replacement therapy on mammographic breast density. Maturitas 2003; 45: 109–118
   PubMed Web of Science ®Google Scholar
• Wolfe J N. The prominent duct pattern as an indicator of cancer risk. Oncology 1969; 23: 149–158
   PubMed Web of Science ®Google Scholar
• Ogden C L, Fryar C D, Carroll M D, Flegal K M. Mean body weight, height, and body mass index, United States 1960–2002. Adv Data 2004; 347: 1–17
   PubMedGoogle Scholar
• Waaseth M, Bakken K, Dumeaux V, et al. Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer postgenome cohort – a cross-sectional analysis. BMC Womens Health 2008; 8: 1
   PubMedGoogle Scholar
• Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat 2008; 107: 103–111
   PubMed Web of Science ®Google Scholar
• Stahlberg C, Pedersen A T, Lynge E, et al. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe. Int J Cancer 2004; 109: 721–727
   PubMed Web of Science ®Google Scholar
• Warren R. Hormones and mammographic breast density. Maturitas 2004; 49: 67–78
   PubMed Web of Science ®Google Scholar
• Laya M B, Gallagher J C, Schreiman J S, et al. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology 1995; 196: 433–437
   PubMed Web of Science ®Google Scholar
• Lundstrom E, Christow A, Kersemaekers W, et al. Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density. Am J Obstet Gynecol 2002; 186: 717–722
   PubMed Web of Science ®Google Scholar
• Harvey J A, Pinkerton J V, Herman C R. Short-term cessation of hormone replacement therapy and improvement of mammographic specificity. J Natl Cancer Inst 1997; 89: 1623–1625
   PubMed Web of Science ®Google Scholar
• Colacurci N, Fornaro F, De Franciscis P, et al. Effects of a short-term suspension of hormone replacement therapy on mammographic density. Fertil Steril 2001; 76: 451–455
   PubMed Web of Science ®Google Scholar
• Rutter C M, Mandelson M T, Laya M B, Seger D J, Taplin S. Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA 2001; 285: 171–176
   PubMed Web of Science ®Google Scholar
• Magnusson C, Baron J A, Correia N, et al. Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer 1999; 81: 339–344
   PubMed Web of Science ®Google Scholar
• Marsden J. Hormone-replacement therapy and breast cancer. Lancet Oncol 2002; 3: 303–311
   PubMed Web of Science ®Google Scholar
• Hofvind S, Sørum R, Haldorsen T, Langmark F. [Incidence of breast cancer before and after implementation of population-based mammography screening]. Tidsskr Nor Laegeforen 2006; 126: 2935–2938
   PubMedGoogle Scholar
• Stuedal A, Ma H, Bernstein L, Pike M C, Ursin G. Does breast size modify the association between mammographic density and breast cancer risk?. Cancer Epidemiol Biomarkers Prev 2008; 17: 621–627
   PubMed Web of Science ®Google Scholar
• Haars G, van Noord P A, Van Gils C H, Grobbee D E, Peeters P H. Measurements of breast density: no ratio for a ratio. Cancer Epidemiol Biomarkers Prev 2005; 14: 2634–2640
   PubMed Web of Science ®Google Scholar